Subject: Cancer Gene Therapy - Table of Contents alert Volume 13 Issue 8

From: "CancerGeneTherapyAlert"<[email-masked]>
Date: Mon, 24 Jul 2006 06:27:12 -0400 (EDT)

| | Accessibility statement Jump to content
| NATURE.COM [email-masked] NATUREJOBS NATUREEVENTS ABOUT NPG

MY ACCOUNT|E-ALERTS|SUBSCRIBE|REGISTER

TABLE OF CONTENTS

| |

Volume 13, Issue 8 (August 2006)
Review
Original Articles
Short Communication

Recommend to your library

Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer. It publishes original laboratory and clinical research papers, case reports and review articles on topics including RNAi approaches, drug resistance, hematopoietic gene transfer, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors. If you can't access the articles,
let your librarian know that you would like full-text access from your desktop.

Review

Top

The rationale for prophylactic cancer vaccines and need for a paradigm shift

R E Sobol

Cancer Gene Ther 2006 13: 725-731; advance online publication, March 10, 2006; 10.1038/sj.cgt.7700950

Abstract | Full Text

Original Articles

Top

Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model

K-W Peng, E M Hadac, B D Anderson, R Myers, M Harvey, S M Greiner, D Soeffker, M J Federspiel and S J Russell

Cancer Gene Ther 2006 13: 732-738; advance online publication, March 10, 2006; 10.1038/sj.cgt.7700948

Abstract | Full Text

FasL gene therapy: a new therapeutic modality for head and neck cancer

S ElOjeimy, J C McKillop, A M El-Zawahry, D H Holman, X Liu, D A Schwartz, T A Day, J-Y Dong and J S Norris

Cancer Gene Ther 2006 13: 739-745; advance online publication, March 17, 2006; 10.1038/sj.cgt.7700951

Abstract | Full Text

An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express -fetoprotein

C-K Chou, J-Y Hung, J-C Liu, C-T Chen and M-C Hung

Cancer Gene Ther 2006 13: 746-752; advance online publication, January 6, 2006; 10.1038/sj.cgt.7700927

Abstract | Full Text

Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model

R Miyahara, S Banerjee, K Kawano, C Efferson, N Tsuda, Y Miyahara, C G Ioannides, S Chada and R Ramesh

Cancer Gene Ther 2006 13: 753-761; advance online publication, March 10, 2006; 10.1038/sj.cgt.7700954

Abstract | Full Text

Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model

D-E Zhu, N Höti, Z Song, L Jin, Z Wu, Q Wu and M Wu

Cancer Gene Ther 2006 13: 762-770; advance online publication, March 17, 2006; 10.1038/sj.cgt.7700952

Abstract | Full Text

Effects of hypoxia and limited diffusion in tumor cell microenvironment on bystander effect of P450 prodrug therapy

M Günther, D J Waxman, E Wagner and M Ogris

Cancer Gene Ther 2006 13: 771-779; advance online publication, March 17, 2006; 10.1038/sj.cgt.7700955

Abstract | Full Text

Enhancement of antitumor activity of herpes simplex virus 134.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide

S Naito, S Obayashi, T Sumi, S Iwai, M Nakazawa, K Ikuta and Y Yura

Cancer Gene Ther 2006 13: 780-791; advance online publication, April 28, 2006; 10.1038/sj.cgt.7700957

Abstract | Full Text

Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation

W M Korn, M Macal, C Christian, M D Lacher, A McMillan, K A Rauen, R S Warren and L Ferrell

Cancer Gene Ther 2006 13: 792-797; advance online publication, April 21, 2006; 10.1038/sj.cgt.7700947

Abstract | Full Text

IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro

L Vujanovic, E Ranieri, A Gambotto, W C Olson, J M Kirkwood and W J Storkus

Cancer Gene Ther 2006 13: 798-805; advance online publication, April 28, 2006; 10.1038/sj.cgt.7700964

Abstract | Full Text

Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53

A Pataer, M A Fanale, J A Roth, S G Swisher and K K Hunt

Cancer Gene Ther 2006 13: 806-814; advance online publication, April 21, 2006; 10.1038/sj.cgt.7700960

Abstract | Full Text

Short Communication

Top

Immunosuppression promotes reovirus therapy of colorectal liver metastases

N Smakman, J D W van der Bilt, D J M van den Wollenberg, R C Hoeben, I H M Borel Rinkes and O Kranenburg

Cancer Gene Ther 2006 13: 815-818; advance online publication, March 10, 2006; 10.1038/sj.cgt.7700949

Abstract | Full Text

Why publish in Cancer Gene Therapy?

Over 60,000 recipients will receive the Table of Contents for the issue in which your research is published.

There are an average of 45,000 page views across the Cancer Gene Therapy web site each month.

On average authors receive a first decision on their paper within 34 working days.

Learn more about the benefits of publishing your paper in Cancer Gene Therapy.

| |
| | | | | |

| |

| |
| |

More Nature Products

More Nature Events

| |

ADVERTISEMENT

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

© 2006 Nature Publishing Group